Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients

American Journal of Pathology

Volumn 181, Issue 4, 2012, Pages 1316-1326

  Yun Chia Chang, Emily ^a   Tsai, Shu Huei ^b   Shun, Chia Tung ^b   Hee, Siow Wey ^b   Chang, Yi Cheng ^b   Tsai, Yun Chih ^b   Tsai, Jaw Shiun ^b   Chen, Hsian Ju ^c   Chou, Jia Wei ^c   Lin, Shih Yao ^c   Chuang, Lee Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c AbGenomics BV   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDOREDUCTASE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN REDUCTASE 2; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; TREATMENT RESPONSE;

ALCOHOL DEHYDROGENASE; ANIMALS; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLUOROURACIL; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; MITOCHONDRIA; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84866522945     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.006     Document Type: Article

References (59)

1. C. Stoicov, R. Saffari, X. Cai, C. Hasyagar, J. Houghton Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling Gene 341 2004 1 17 (Pubitemid 39335879)
2. T. Matsuzaki, M. Yashiro, R. Kaizaki, K. Yasuda, Y. Doi, T. Sawada, M. Ohira, K. Hirakawa Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer Cancer Sci 100 2009 2402 2410
3. B. Wu, Q. Zhang, W. Shen, J. Zhu Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line Mol Cell Biochem 313 2008 125 132
4. D. Wang, R.N. Dubois Prostaglandins and cancer Gut 55 2006 115 122 (Pubitemid 41820645)
5. M.T. Wang, K.V. Honn, D. Nie Cyclooxygenases, prostanoids, and tumor progression Cancer Metastasis Rev 26 2007 525 534 (Pubitemid 350115125)
6. S.V. Fulzele, A. Chatterjee, M.S. Shaik, T. Jackson, N. Ichite, M. Singh 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors Anticancer Drugs 18 2007 65 78 (Pubitemid 44963416)
7. N. Takahashi, T. Okumura, W. Motomura, Y. Fujimoto, I. Kawabata, Y. Kohgo Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells FEBS Lett 455 1999 135 139 (Pubitemid 29322796)
8. W.K. Leung, A.H. Bai, V.Y. Chan, J. Yu, M.W. Chan, K.F. To, J.R. Wu, K.K. Chan, Y.G. Fu, F.K. Chan, J.J. Sung Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells Gut 53 2004 331 338 (Pubitemid 38241325)
9. P.C. Konturek, J. Kania, V. Kukharsky, M. Raithel, M. Ocker, K. Rembiasz, E.G. Hahn, S.J. Konturek Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection J Pharmacol Sci 96 2004 134 143 (Pubitemid 39469604)
10. Y.X. Chen, X.Y. Zhong, Y.F. Qin, W. Bing, L.Z. He 15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line World J Gastroenterol 9 2003 2149 2153 (Pubitemid 37321434)
11. X.M. Ma, H. Yu, N. Huai Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma World J Gastroenterol 15 2009 3874 3883
12. Y. Shi, Z. Hu, C. Wu, J. Dai, H. Li, J. Dong, M. Wang, X. Miao, Y. Zhou, F. Lu, H. Zhang, L. Hu, Y. Jiang, Z. Li, M. Chu, H. Ma, J. Chen, G. Jin, W. Tan, T. Wu, Z. Zhang, D. Lin, H. Shen A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 Nat Genet 43 2011 1215 1218
13. W.L. Chou, L.M. Chuang, C.C. Chou, A.H. Wang, J.A. Lawson, G.A. FitzGerald, Z.F. Chang Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation J Biol Chem 282 2007 18162 18172 (Pubitemid 47100215)
14. Y.H. Wu, T.P. Ko, R.T. Guo, S.M. Hu, L.M. Chuang, A.H. Wang Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2 Structure 16 2008 1714 1723
15. L. Lalier, P.F. Cartron, C. Olivier, C. Loge, G. Bougras, J.M. Robert, L. Oliver, F.M. Vallette Prostaglandins antagonistically control Bax activation during apoptosis Cell Death Differ 18 2011 528 537
16. P. Kakkar, B.K. Singh Mitochondria: a hub of redox activities and cellular distress control Mol Cell Biochem 305 2007 235 253 (Pubitemid 47517185)
17. N. Festjens, T. Vanden Berghe, P. Vandenabeele Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response Biochim Biophys Acta 1757 2006 1371 1387 (Pubitemid 44472550)
18. V. Borutaite Mitochondria as decision-makers in cell death Environ Mol Mutagen 51 2010 406 416
19. G. Kroemer, J. Pouyssegur Tumor cell metabolism: cancer's Achilles' heel Cancer Cell 13 2008 472 482 (Pubitemid 351766797)
20. S. Krishna, I.C. Low, S. Pervaiz Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2 Biochem J 435 2011 545 551
21. J.F. Curtin, M. Donovan, T.G. Cotter Regulation and measurement of oxidative stress in apoptosis J Immunol Methods 265 2002 49 72 (Pubitemid 34628804)
22. J. Fang, T. Seki, H. Maeda Therapeutic strategies by modulating oxygen stress in cancer and inflammation Adv Drug Deliv Rev 61 2009 290 302
23. S. Cagnol, J.C. Chambard ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence FEBS J 277 2010 2 21
24. S. Orrenius Reactive oxygen species in mitochondria-mediated cell death Drug Metab Rev 39 2007 443 455 (Pubitemid 47355728)
25. J.J. Lemasters, T. Qian, C.A. Bradham, D.A. Brenner, W.E. Cascio, L.C. Trost, Y. Nishimura, A.L. Nieminen, B. Herman Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death J Bioenerg Biomembr 31 1999 305 319 (Pubitemid 30058566)
26. M. Wu, A. Neilson, A.L. Swift, R. Moran, J. Tamagnine, D. Parslow, S. Armistead, K. Lemire, J. Orrell, J. Teich, S. Chomicz, D.A. Ferrick Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells Am J Physiol Cell Physiol 292 2007 C125 C136
27. R.J. Deberardinis, N. Sayed, D. Ditsworth, C.B. Thompson Brick by brick: metabolism and tumor cell growth Curr Opin Genet Dev 18 2008 54 61 (Pubitemid 351694453)
28. R.J. Lin, H.P. Yu, B.L. Chang, W.C. Tang, C.L. Liao, Y.L. Lin Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection J Immunol 183 2009 8035 8043
29. Y.C. Chang, Y.F. Chiu, L.L. Ho, C.T. Ting, K.C. Shih, J.D. Curb, Y.D. Chen, H.Y. Li, L.M. Chuang TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance J Mol Med (Berl) 88 2010 183 192
30. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
31. M. Ahamed, M.J. Akhtar, M.A. Siddiqui, J. Ahmad, J. Musarrat, A.A. Al-Khedhairy, M.S. AlSalhi, S.A. Alrokayan Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells Toxicology 283 2011 101 108
32. G. Fritz, I. Just, B. Kaina Rho GTPases are over-expressed in human tumors Int J Cancer 81 1999 682 687 (Pubitemid 29214373)
33. E.F. Mason, J.C. Rathmell Cell metabolism: an essential link between cell growth and apoptosis Biochim Biophys Acta 1813 2011 645 654
34. C. Favre, A. Zhdanov, M. Leahy, D. Papkovsky, R. O'Connor Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells Oncogene 29 2010 3964 3976
35. G. Santamaria, M. Martínez-Diez, I. Fabregat, J.M. Cuezva Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase Carcinogenesis 27 2006 925 935
36. Y. Mebratu, Y. Tesfaigzi How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer Cell Cycle 8 2009 1168 1175
37. Y.J. Lee, H.N. Cho, J.W. Soh, G.J. Jhon, C.K. Cho, H.Y. Chung, S. Bae, S.J. Lee, Y.S. Lee Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation Exp Cell Res 291 2003 251 266 (Pubitemid 37338696)
38. R. Kim, K. Tanabe, M. Emi, Y. Uchida, H. Inoue, T. Toge Inducing cancer cell death by targeting transcription factors Anticancer Drugs 14 2003 3 11 (Pubitemid 36177349)
39. M. Kaminishi Diversity of gastric carcinogenesis Oncology 69 Suppl 1 2005 1 8
40. L. Wu, C. Yan, M. Czader, O. Foreman, J.S. Blum, R. Kapur, H. Du Inhibition of peroxisome proliferator-activated receptor-gamma in myeloid lineage cells induces systemic inflammation, immunosuppression and tumorigenesis Blood 119 2012 115 126
41. E. Maniati, M. Bossard, N. Cook, J.B. Candido, N. Emami-Shahri, S.A. Nedospasov, F.R. Balkwill, D.A. Tuveson, T. Hagemann Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice J Clin Invest 121 2011 4685 4699
42. V. Quidville, N. Segond, E. Pidoux, R. Cohen, A. Jullienne, S. Lausson Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase Endocrinology 145 2004 2561 2571 (Pubitemid 38535084)
43. M.A. Hull, S.H. Gardner, G. Hawcroft Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer Cancer Treat Rev 29 2003 309 320 (Pubitemid 37069661)
44. T. Inada, S. Kikuyama, A. Ichikawa, S. Igarashi, Y. Ogata Bcl-2 expression as a prognostic factor of survival of gastric carcinoma Anticancer Res 18 1998 2003 2010 (Pubitemid 28344862)
45. Y. Koshida, M. Saegusa, I. Okayasu Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study Br J Cancer 75 1997 367 373 (Pubitemid 27051051)
46. M. Saegusa, Y. Takano, I. Okayasu Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia J Cancer Res Clin Oncol 121 1995 357 363
47. K. Zafirellis, A. Karameris, N. Milingos, G. Androulakis Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors Anticancer Res 25 2005 3629 3636 (Pubitemid 41105253)
48. H.K. Lee, H.S. Lee, H.K. Yang, W.H. Kim, K.U. Lee, K.J. Choe, J.P. Kim Prognostic significance of Bcl-2 and p53 expression in gastric cancer Int J Colorectal Dis 18 2003 518 525 (Pubitemid 37265866)
49. R. Klein, H. Vollmers, H. Mullerhermelink Different expression of Bcl-2 in diffuse and intestinal type stomach carcinomas Oncology Rep 3 1996 825 828 (Pubitemid 26323731)
50. C.J. van der Woude, J.H. Kleibeuker, A.T. Tiebosch, M. Homan, A. Beuving, P.L. Jansen, H. Moshage Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins J Clin Pathol 56 2003 699 702 (Pubitemid 37094132)
51. M.D. Jacobson, J.F. Burne, M.P. King, T. Miyashita, J.C. Reed, M.C. Raff Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA Nature 361 1993 365 369 (Pubitemid 23041631)
52. R. Dey, C.T. Moraes Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells J Biol Chem 275 2000 7087 7094 (Pubitemid 30146256)
53. Z.X. Chen, S. Pervaiz Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells [Erratum appeared in Cell Death Differ 2012, 19:551] Cell Death Differ 14 2007 1617 1627 (Pubitemid 47278847)
54. Z.X. Chen, S. Pervaiz Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2 Cell Death Differ 17 2010 408 420
55. R. Kahl, A. Kampkötter, W. Wätjen, Y. Chovolou Antioxidant enzymes and apoptosis Drug Metab Rev 36 2004 747 762 (Pubitemid 39453072)
56. T.S. Hwang, H.K. Choi, H.S. Han Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa Eur J Surg Oncol 33 2007 474 479 (Pubitemid 46591167)
57. M. Monari, J. Foschi, C. Calabrese, G. Liguori, G. Di Febo, F. Rizzello, P. Gionchetti, A. Trinchero, G.P. Serrazanetti Implications of antioxidant enzymes in human gastric neoplasms Int J Mol Med 24 2009 693 700
58. M. Monari, A. Trinchero, C. Calabrese, O. Cattani, G.P. Serrazanetti, J. Foschi, A. Fabbri, D. Zahlane, G. Di Febo, V. Tonini, M. Cervellera, M.R. Tosi, V. Tugnoli Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer Biomarkers 11 2006 574 584 (Pubitemid 44614828)
59. N. Vanlangenakker, T. Vanden Berghe, D.V. Krysko, N. Festjens, P. Vandenabeele Molecular mechanisms and pathophysiology of necrotic cell death Curr Mol Med 8 2008 207 220 (Pubitemid 351982539)